Macquarie Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-832
| Closed | -$72K | – | 1918 |
|
|
2022
Q3 | $72K | Sell |
832
-579
| -41% | -$50.1K | ﹤0.01% | 1841 |
|
|
2022
Q2 | $42K | Hold |
1,411
| – | – | ﹤0.01% | 2095 |
|
|
2022
Q1 | $45 | Sell |
1,411
-40,750
| -97% | -$1.3K | ﹤0.01% | 2164 |
|
|
2021
Q4 | $1.88M | Buy |
42,161
+251
| +0.6% | +$11.2K | ﹤0.01% | 1390 |
|
|
2021
Q3 | $2.11M | Hold |
41,910
| – | – | ﹤0.01% | 1368 |
|
|
2021
Q2 | $3.29M | Sell |
41,910
-1,022
| -2% | -$80.2K | ﹤0.01% | 1257 |
|
|
2021
Q1 | $2.45M | Buy |
42,932
+8,091
| +23% | +$462K | ﹤0.01% | 1131 |
|
|
2020
Q4 | $2.92M | Buy |
34,841
+31,030
| +814% | +$2.6M | ﹤0.01% | 998 |
|
|
2020
Q3 | $137K | Hold |
3,811
| – | – | ﹤0.01% | 1701 |
|
|
2020
Q2 | $92K | Buy |
+3,811
| New | +$92K | ﹤0.01% | 1774 |
|